LUNG SQUAMOUS CELL CARCINOMA STAGE I

LUNG SQUAMOUS CELL CARCINOMA STAGE I was reported 43 times

LUNG SQUAMOUS CELL CARCINOMA STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Paramagnetic Contrast Agent [EPC] 1 0.0002
1 Parenteral Iron Replacement [EPC] 2 0.0001
2 Selective T Cell Costimulation Modulator [EPC] 6 0.0000
3 Alkaloid [EPC] 1 0.0000
4 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
6 Interleukin-17A Antagonist [EPC] 1 0.0000
7 Pyridone [EPC] 1 0.0000
8 Aminosalicylate [EPC] 2 0.0000
9 Aldosterone Antagonist [EPC] 3 0.0000
10 Vitamin D [EPC] 5 0.0000
11 Cholinergic Nicotinic Agonist [EPC] 1 0.0000
12 Vitamin B12 [EPC] 5 0.0000
13 alpha-Adrenergic Blocker [EPC] 2 0.0000
14 Catecholamine [EPC] 1 0.0000
15 Vitamin C [EPC] 5 0.0000
16 Parathyroid Hormone Analog [EPC] 1 0.0000
17 Proteasome Inhibitor [EPC] 1 0.0000
18 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
19 Corticosteroid [EPC] 11 0.0000
20 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
21 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
22 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
23 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
24 Calcium [EPC] 1 0.0000
25 beta-Adrenergic Blocker [EPC] 2 0.0000
26 Benzodiazepine [EPC] 4 0.0000
27 Estrogen [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 3 0.0000
29 Interferon beta [EPC] 1 0.0000
30 Insulin Analog [EPC] 2 0.0000
31 Loop Diuretic [EPC] 2 0.0000
32 Alkylating Drug [EPC] 1 0.0000
33 Thalidomide Analog [EPC] 2 0.0000
34 Opioid Agonist [EPC] 1 0.0000
35 Factor Xa Inhibitor [EPC] 1 0.0000
36 Osmotic Laxative [EPC] 1 0.0000
37 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
38 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
39 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
40 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000